Praloy Chakraborty Selected Research

azumolene

1/2022

Effects of azumolene on arrhythmia substrate in a model of recurrent long-duration ventricular fibrillation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Praloy Chakraborty Research Topics

Disease

5	Heart Failure 01/2022 - 01/2019
4	Cardiac Arrhythmias (Arrythmia) 01/2022 - 11/2020
2	Fibrosis (Cirrhosis) 01/2022 - 01/2019
2	Ischemia 01/2022 - 07/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2019
2	Cardiomyopathies (Cardiomyopathy) 12/2021 - 05/2021
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 05/2021 - 01/2021
2	Congenital Heart Defects (Congenital Heart Defect) 01/2021 - 01/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2019 - 08/2018
1	Cardiomegaly (Heart Hypertrophy) 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Ventricular Fibrillation 01/2022
1	Cardiotoxicity 12/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2021
1	Shock 05/2021
1	Death (Near-Death Experience) 05/2021
1	Tetralogy of Fallot (Fallot Tetralogy) 05/2021
1	Sinus Tachycardia 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Sudden Death 11/2020
1	Tachycardia (Tachyarrhythmias) 10/2020
1	Thyrotoxicosis 10/2020
1	Atrial Fibrillation 01/2020
1	Insulin Resistance 01/2019
1	Vitamin D Deficiency 01/2019
1	Muscular Diseases (Myopathy) 08/2018
1	Supraventricular Tachycardia 01/2018
1	Torsades de Pointes (Torsade de Pointes) 03/2012
1	Ventricular Tachycardia 03/2012
1	Aneurysm (Aneurysms) 01/2010
1	Infections 09/2005

Drug/Important Bio-Agent (IBA)

2	FructoseIBA 01/2022 - 01/2019
2	CalciumIBA 12/2021 - 07/2021
2	Amiodarone (Amiodarona)FDA LinkGeneric 10/2020 - 03/2012
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2019 - 08/2018
1	azumoleneIBA 01/2022
1	paricalcitol (Zemplar)FDA Link 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	ParaffinIBA 01/2022
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2022
1	Dantrolene (Dantrium)FDA LinkGeneric 12/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2021
1	Anti-Arrhythmia AgentsIBA 07/2021
1	empagliflozinIBA 07/2021
1	NAD (NADH)IBA 07/2021
1	IvabradineIBA 01/2021
1	ibrutinibIBA 11/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 11/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2019
1	PalmitatesIBA 01/2019
1	ReninIBA 01/2019
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	Phenytoin (Dilantin)FDA LinkGeneric 03/2012
1	Atropine FDA LinkGeneric 03/2012
1	MagnesiumIBA 03/2012
1	Lidocaine (Xylocaine)FDA LinkGeneric 03/2012
1	Immunoglobulin M (IgM)IBA 09/2005
1	Immunoglobulin G (IgG)IBA 09/2005

Therapy/Procedure

3	Therapeutics 05/2021 - 08/2018
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 05/2021 - 01/2021
1	Transplantation 05/2021
1	Electric Countershock (Cardioversion) 01/2021
1	Defibrillators (Defibrillator) 01/2021
1	Catheter Ablation 01/2021
1	Fontan Procedure (Fontan Operation) 10/2020
1	Heart Transplantation (Grafting, Heart) 10/2020
1	Drug-Eluting Stents 01/2010